Thomas H. Vanderford

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Vijayakumar Velu, Kehmia Titanji, Baogong Zhu et al. · Nature · 2008 · 752 citations · Full text

Pd-1 Blockade, Immunology, Antiviral Response +4

Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys

Steven E. Bosinger, Qingsheng Li, Shari N. Gordon et al. · Journal of Clinical Investigation · 2009 · 400 citations · Full text

Genetics, Innate Immune System, Immunology +22

Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections

Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford et al. · Nature Medicine · 2008 · 370 citations

Divergent Tlr7, Human Retrovirus, Pathogenesis +11

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 311 citations · Full text

Viral Persistence, Human Retrovirus, Immunodeficiencies +14

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

Enoch Muyanja, Aloysius Ssemaganda, Pearline Ngauv et al. · Journal of Clinical Investigation · 2014 · 219 citations · Full text